AtaiBeckley (ATAI) Cash from Operations (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Cash from Operations of 21090000.0 in Q1 2026, down 18.21% quarter-over-quarter from 17841000.0 in Q1 2025, and down 18.21% on a YoY basis from 25785820.31 in Q1 2025.
AtaiBeckley (ATAI) Cash from Operations (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Cash from Operations across 6 years of filings, most recently posting 23261000.0 for Q3 2025.
- Cash from Operations for Q3 2025 came in at 23261000.0, down 20.27% year-over-year; the trailing twelve-month figure through Sep 2025 was 79491000.0 (up 0.77% YoY), and the FY2024 annual result was 82437000.0, up 2.0% from the prior year.
- Cash from Operations was 21090000.0 for Q1 2026 at AtaiBeckley, down from 17841000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 17841000.0 in Q1 2025 to a low of 21090000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 21931000.0 (2022), against an average of 20498105.26.
- Across the five-year window, Cash from Operations sank 1256.09% in 2022 and soared 34.28% in 2023, its largest moves.
- AtaiBeckley's Cash from Operations stood at 20509000.0 in 2021, then slumped by 48.74% to 30505000.0 in 2022, then rose by 28.01% to 21962000.0 in 2023, then slipped by 10.62% to 24295000.0 in 2024, then grew by 4.26% to 23261000.0 in 2025.
- The last three Cash from Operations figures came in at 23261000.0 (Q3 2025), 14094000.0 (Q2 2025), and 17841000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -21.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.09 Mn |
| Mar 31, 2026 | -21.09 Mn |
| Sep 30, 2025 | -23.26 Mn |
| Sep 30, 2025 | -23.26 Mn |
| Jun 30, 2025 | -14.09 Mn |
| Jun 30, 2025 | -14.09 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Sep 30, 2024 | -19.34 Mn |
| Sep 30, 2024 | -19.34 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Mar 31, 2024 | -22.57 Mn |
| Mar 31, 2024 | -22.57 Mn |
| Dec 31, 2023 | -21.96 Mn |
| Dec 31, 2023 | -21.96 Mn |